IOL Chemicals & Pharmaceuticals Ltd has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company's Pharmaceuticals API products 'IBUPROFEN and 'FENOFIBRATE'. The approval of Korean FDA re-establishes the Company's efforts to keep the highest quality standards and to increase presence in the regulated markets. This will strengthen Company's presence in South Korean market.
Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 607.55 as compared to the previous close of Rs. 599.35. The total number of shares traded during the day was 78573 in over 4262 trades.
The stock hit an intraday high of Rs. 614.65 and intraday low of 589.55. The net turnover during the day was Rs. 47304818.00.